Targeting Rare Diseases
AOP Orphan is a European pioneer in the development, marketing and distribution of medicines for people with rare and complex diseases.
Team Members
“Many patients with a rare disease suffer from a massive diagnostic delay. Our ambition is to shorten this way by raising disease awareness in cooperation with health care professionals and providing individual solutions to improve their life quality.”
“Working together every day in a motivated Austrian team to bring efficacious drugs to patients suffering from rare diseases is gratifying.”
“Have been working in hematology and oncology for more than twelve years, I have the wonderful chance to share these experiences with highly skilled and motivated colleagues at AOP Orphan for the benefit of Austrian patients. We work together to change patients lives in a positive way!”
Facts & Figures
AOP Orphan is fully dedicated to pharmaceutical and clinical development as well as commercialization of drugs for more than 20 years already.
Our motivation at AOP Orphan is to help patients who suffer from rare diseases. We achieve this cooperating with stakeholders of the Austrian health care system. Partnerships within pharmaceutical and health care industry are crucial for finding and providing solutions for patients, especially in the treatment of orphan diseases.
Austria occupies a special position among many countries where AOP Orphan is represented. In this market, the company began its development in 1996 and this is where AOP Orphan also has its broad and solid base with a head office. AOP Orphan Austria is a team of around thirteen employees in the Marketing & Sales, and Medical for all three therapeutic divisions.
HematoOncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders.
